MIRA INFORM REPORT

 

 

Report No. :

349264

Report Date :

20.11.2015

 

IDENTIFICATION DETAILS

 

Name :

PHAARMASIA LIMITED

 

 

Registered Office :

16, Phase – III, Industrial Development Area, Jeedimelta, Hyderabad – 500055, Telangana

Tel. No.:

91-40-23095002

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

06.02.1981

 

 

Com. Reg. No.:

36-002915

 

 

Capital Investment / Paid-up Capital :

Rs.68.270 Million

 

 

CIN No.:

[Company Identification No.]

L24239TG1981PLC002915

 

 

IEC No.:

0991011163

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCP2286M

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Pharmaceutical Formulation and Cosmetics.

 

 

No. of Employees :

60 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 370000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Phaarmasia Limited is a pharmaceutical company. It is a manufacturer of pharmaceutical formulation and cosmetics. The company was founded in 1981 and is based in Hyderabad, Telangana. It is having satisfactory track record.

 

Turnover and profit of the company has declined during FY 2015. However, networth base of the company is satisfactory. General financial position of the company is normal and acceptable for business dealings.

 

Further, the rating also takes into consideration debt free balance sheet and company’s long track record of business operation.

 

Trade relations are reported as fair. Business is active. Payments terms are reported as slow but correct.

 

In view of long track record and acceptable financial base, the company can be considered normal for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

HENKEL RATING

 

HENKEL’s Rating :

350 (Significant Risk)

 

Credit Rating

Henkel Rating (Customer Risk Assesment- CRA)

Mira Inform

Risk Category

Credit Limit

Description

Aaa

100

Inter Company, credit limit not required

Very low risk (blue ships)

Aa

200, 201

(120% of Gross Annualised Sales/365)*Credit Term.

Low risk

A

300, 301

(100% of Gross Annualised Sales/365)*Credit Term.

Moderate risk

Ba

350

(90% of Gross Annualised Sales/365)*Credit Term.

Significant risk

B

400

(80% of Gross Annualised Sales/365)*Credit Term.

High risk

450

Very high risk

Ca or C

500*

NIL/ Legal/ Bad/No Transaction

Doubtful accounts

007*

NIL

Small unrated customers

009*

NIL

Inactive customers

999*

Initially First Invoice vales, CRA will be done and based on report the CL would get revised.

New customer

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Sunil

Designation :

Assistant Accountant

Contact No.:

91-40-23095002

Date :

17.11.2015

 

 

LOCATIONS

 

Registered Office/ Factory :

16, Phase – III, Industrial Development Area, Jeedimelta, Hyderabad – 500055, Telangana, India

Tel. No.:

91-40-23095002

Fax No.:

91-40-23097323

E-Mail :

phaarmasia@yahoo.com

phaarmasia@gmail.com

Website :

www.phaarmasia.com

Location :

Owned

Locality:

Industrial

 

 

DIRECTORS

 

AS ON 31.03.2015

 

Name :

Mr. Maneesh R. Sapte

Designation :

Managing Director

 

 

Name :

Mr. Y. N. Bhaskara Rao

Designation :

Whole-time Director

 

 

Name :

Mr. Vinay Ramakant Sapte

Designation :

Non-executive Director

 

 

Name :

Mrs. Rashmi Vinay Sapte

Designation :

Non-Executive Director

 

 

Name :

Mr. Bharat B. Merchant

Designation :

Non-Executive Independent Director

 

 

Name :

Mr. Bhupinder N. Garg

Designation :

Non-executive Independent Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Sunil

Designation :

Assistant Accountant

 

 

 SHAREHOLDING PATTERN

 

AS ON 30.09.2015

 

Category of Shareholder

Total No. of Shares

Total Shareholding as a % of Total No. of Shares

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

5014232

73.45

http://www.bseindia.com/include/images/clear.gifSub Total

5014232

73.45

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

5014232

73.45

(B) Public Shareholding

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

3960

0.06

http://www.bseindia.com/include/images/clear.gifSub Total

3960

0.06

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

17324

0.25

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 million

1383557

20.27

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 million

403148

5.91

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

4739

0.07

http://www.bseindia.com/include/images/clear.gifClearing Members

3587

0.05

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

1152

0.02

http://www.bseindia.com/include/images/clear.gifSub Total

1808768

26.49

Total Public shareholding (B)

1812728

26.55

Total (A)+(B)

6826960

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1)

0

0.00

http://www.bseindia.com/include/images/clear.gif(2)

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

6826960

0.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Formulation and Cosmetics.

 

 

Products :

  • Pharmaceutical Formulation
  • Pharmaceutical Cosmetics

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

L\C, Cheque and Credit

 

 

Purchasing :

L\C, Cheque and Credit

 

PRODUCTION STATUS: AS ON 31.03.2015

 

Particulars

 

Installed Capacity

(on Single Shift Basis)

- Liquids in KL

 

6000 P.A.

- Tablets in Millions

 

5400 P.A.

- Capsules in Millions

 

3000 P.A.

- Pastes, Creams and Ointments in M.T

 

4500 P.A.

 

 

 

 

Particulars

 

Actual Production

 

a) For conversion

 

 

Liquids (KL)

 

201.670

Pastes & Creams(MT)

 

2635.130

 

 

 

b) Own Production :

 

 

Liquids (KL)

 

0.000

Tablets(Millions)

 

543.990

Pastes & Creams(MT)

 

0.000

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

End Users and OEMs

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

60 (Approximately)

 

 

Bankers :

  • Bank of Madura Limited, Koti, Hyderabad, Telangana, India

 

Banker Name

HDFC Bank Limited

Branch Address

S.D. Road, Secunderabad, Telangana, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

 

Financial Institute  :

  • India Equipment Leasind Limited, 21 No. Patullos Road, Madras, Tamilnadu, India
  • Nagarjuna Investment Trust Limited, 26; Nagarjuna Hills Panjagutta, Hyderabad - 500482, Telangana, India

 

 

Statutory Auditors:

 

Name :

K S. Ramakrishna and Company

Chartered Accountants

Address :

5-9-22/38/2, Adarsh Nagar, Hyderabad – 500063, Telangana, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Related Parties:

  • Maneesh Pharmaceuticals Limited
  • Svizera Health Remedies

 

 

Holding Company:

  • Maneesh Pharmaceuticals Limited

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6826960

Equity Shares

Rs.10/- each

Rs.68.270 Million

 

 

 

 

 

 

Reconciliation of the Shares outstanding at the beginning and at the end of the reporting period:

 

Particulars

AS ON 31.03.2015

 

No. of shares

Amount

Outstanding at the beginning of the year

6826960

68.270

Shares issued during the year

0.000

0.000

outstanding at the end of the year

6826960

68.270

 

 

Details of Shareholders holding more than 5% (percent) shares in the Company:

 

Particulars

AS ON 31.03.2015

 

No. of shares

% of holding

 

Maneesh Pharmaceuticals Limited

3014232

44.15

Svizera Labs Private Limited

2000000

29.30

 

 

The Company has only one class of equity shares having a par value of Rs.10 per share. Each holder of equity shares is entitled to one vote per share. In the event of liquidation of the Company the holders of equity shares will be entiled to receive remaining assets of the Company after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

FINANCIAL DETAILS ATTACHED

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

0.174

0.000

NA

Cash generated from operations

4.965

2.243

1.280

Net cash flow operating activities

4.791

1.698

0.989

 

 

STOCK PRICES

 

Face Value

--

Market Value

Rs.24.70/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

68.270

68.270

68.270

Reserves & Surplus

6.915

6.209

62.812

Net worth

75.185

74.479

131.082

 

 

 

 

Long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

72.888

212.845

187.402

 

 

192.017

(11.954)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

72.888

212.845

187.402

Profit

34.001

3.527

1.395

 

46.65%

1.66%

0.74%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

FUTURE OUTLOOK:

 

The new government is likely to give more thrust towards infrastructure growth which helps in more transportation activities. This in turn will help their retreading industry; they forecast a healthy growth during the financial year 2015-2016.

 

INDUSTRY OVERVIEW:

Generally the Pharmaceutical Industry is registering better performance inspite of severe competition from multinational companies. There are many opportunities in 3 world countries for export of various formulations and drugs. The management is confident of improving the operations by focusing on manufacturing of Cosmetics and Oral Contraceptive Pills.

 

OUTLOOK:

The Company continues to explore the possibilities of expansion in its activities and will make the necessary investment when attractive opportunities arise.

 

 


UNAUDITED FINANCIAL RESULTS FOR THE    QUARTER ENDED 30TH SEPTEMBER, 2015

 

(Rs. In Million)

Particulars

Quarter Ended

( Unaudited)

Quarter Ended

( Unaudited)

Year Ended

( Unaudited)

 

30.09.2015

30.06.2015

30.09.2015

 

 

 

 

1. Income from operations

 

 

 

a) Net sales/ Income from operation (net of excise duty)

43.486

21.336

64.822

b) Other operating income

1.353

1.053

2.406

Total income from Operations(net)

44.838

22.388

62.227

2.Expenditure

 

 

 

a) Cost of material consumed

12.901

13.592

26.493

b) Purchases of stock in trade

0.000

0.000

0.000

c) Changes in inventories of finished goods, work-in-progress and stock-in-trade

11.082

(11.296)

(0.214)

d) Employees benefit expenses

3.637

3.429

7.066

e) Depreciation and amortization expenses

1.590

1.469

3.059

f) Other expenditure

14.268

14.548

28.816

Total expenses

43.478

21.742

65.220

3. Profit from operations before other income and financial costs

1.361

0.646

2.007

4. Other income

0.000

0.000

0.000

5. Profit from ordinary activities before finance costs

1.361

0.646

2.007

6. Finance costs

0.068

0.048

0.116

7. Net profit/(loss) from ordinary activities after finance costs but before exceptional items

1.293

0.598

1.891

8. Exceptional item

0.000

0.000

0.000

9. Profit from ordinary activities before tax Expense:

1.293

0.598

1.891

10.Tax expenses

(0.38)

(0.179)

(0.567)

11.Net Profit / (Loss) from ordinary activities after tax (9-10)

0.905

0.419

1.324

12.Extraordinary Items (net of tax expense)

0.000

0.000

0.000

13.Net Profit / (Loss) for the period (11 -12)

0.905

0.419

1.324

14.Paid-up equity share capital (Face value Rs.10/- per share)

68.270

68.270

68.270

15. Reserve excluding Revaluation Reserves as per balance sheet of previous accounting year

0.000

0.000

0.000

16.i) Earnings per share (before extraordinary items) of Rs.10/- each) (not annualised):

 

 

 

(a) Basic

0.1326

0.0614

0.1939

(b) Diluted

0.1326

0.0614

0.1939

 

 

 

 

 

 

 

 

Particulars

Quarter Ended

( Unaudited)

Quarter Ended

( Unaudited)

Year Ended

( Unaudited)

 

30.09.2015

30.06.2015

30.09.2015

A. Particulars of shareholding

 

 

 

1. Public Shareholding

 

 

 

- Number of shares

1812728

1812728

1812728

- Percentage of shareholding

26.55

26.55

26.55

2. Promoters and Promoters group Shareholding-

 

 

 

a) Pledged /Encumbered

 

 

 

Number of shares

NIL

NIL

NIL

Percentage of shares (as a % of total shareholding of the promoter and promoter group)

NIL

NIL

NIL

Percentage of shares (as a % of total share capital of the company)

NIL

NIL

NIL

 

 

 

 

b) Non  Encumbered

 

 

 

Number of shares

5014232

5014232

5014232

Percentage of shares (as a % of total shareholding of the promoter and promoter group)

100

100

100

 

 

 

 

Percentage of shares (as a % of total share capital of the company)

73.45%

73.45%

73.45%

 

 

 

 

B. Investor Complaints

 

 

 

Pending at the beginning of the quarter

 

 

0

Receiving during the quarter

 

 

0

Disposed of during the quarter

 

 

0

Remaining unreserved at the end of the quarter

 

 

0

 

Notes:

 

  1. The Auditor of the Company has carried out the audit of the above financial results
  2. The above audited result have been taken on record at a meeting by the Audit Committee and the Board of Directors of the Company on 14th November, 2015
  3. Previous Periods/ Year’s figures have been regrouped/ rearranged whenever necessary.

 

 


STATEMENT OF ASSETS AND LIABILITIES

 

SOURCES OF FUNDS

 

 

30.09.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

 

68.270

(b) Reserves & Surplus

 

 

 51.335

(c) Money received against share warrants

 

 

 0.000

 

 

 

 

(2) Share Application money pending allotment

 

 

 0.000

Total Shareholders’ Funds (1) + (2)

 

 

119.604

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

 

0.000

(b) Deferred tax liabilities (Net)

 

 

 0.000

(c) Other long term liabilities

 

 

 0.983

(d) long-term provisions

 

 

 3.333

Total Non-current Liabilities (3)

 

 

4.316

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

 

0.000

(b) Trade payables

 

 

 76.036

(c) Other current liabilities

 

 

 34.270

(d) Short-term provisions

 

 

 4.690

Total Current Liabilities (4)

 

 

114.996

 

 

 

 

TOTAL

 

 

238.916

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

 

142.970

(ii) Intangible Assets

 

 

0.000

(iii) Capital work-in-progress

 

 

 0.000

(iv) Intangible assets under development

 

 

 0.000

(b) Non-current Investments

 

 

 0.000

(c) Deferred tax assets (net)

 

 

 0.646

(d)  Long-term Loan and Advances

 

 

 2.487

(e) Other Non-current assets

 

 

 0.000

Total Non-Current Assets

 

 

146.103

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

 

0.000

(b) Inventories

 

 

 5.908

(c) Trade receivables

 

 

 79.214

(d) Cash and cash equivalents

 

 

 2.609

(e) Short-term loans and advances

 

 

 0.028

(f) Other current assets

 

 

 5.054

Total Current Assets

 

 

92.813

 

 

 

 

TOTAL

 

 

238.916

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

90343008

31/12/1994

3,740,000.00

INDIA EQUIPMENT LEASIND LIMITED

21 NO. PATULLOS ROAD, MADRAS, TAMILNADU, INDIA

-

2

90339952

29/06/1993

788,248.00

NAGARJUNA INVESTMENT TRUST LIMITED

26; NAGARJUNA HILLS PANJAGUTTA; HYDERABAD - 500482, TELANGANA INDIA

-

3

90340793

10/06/1993

336,140.00

NAGARJUNA INVESTMENT TRUST LIMITED

26; NAGARJUNA HILLS PANJAGUTTA, HYDERABAD - 500482, TELANGANA INDIA

-

4

90339904

25/02/1992

1,000,000.00

BANK OF MADURA LIMITED

K J MARKET; KOTI, HYDERABAD TELANGANA, INDIA

-

5

90339896

07/11/1991

1,800,000.00

BANK OF MADHURA LIMITED

KHOTI, HYDERABAD, TELANGANA, INDIA

-

6

90340710

21/06/1991

1,525,000.00

BANK OF MADURA LIMITED

K J MARKET KOTI, HYDERABAD, TELANGANA, INDIA

-

7

90340707

17/09/1992 *

587,300.00

BANK OF MADURA LIMITED

KOTI, HYDERABAD, TELANGANA, INDIA

-

8

90339878

25/05/1991

3,750,000.00

BANK OF MADURA LIMITED

KHOTI, HYDERABAD, TELANGANA, INDIA

-

9

90339845

07/08/1990 *

200,000.00

BANK OF MADURA LIMITED

P. B. NO. 510 KOTI, HYDERABAD - 500195, TELANGANA, INDIA

-

10

90340489

30/05/1992 *

800,000.00

BANK OF MADURA LIMITED

KOTI, HYDERABAD, TELANGANA, INDIA

-

 

* Date of charge modification

 

 

FIXED ASSETS

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.66.11

UK Pound

1

Rs.101.03

Euro

1

Rs.70.78

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUV

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

GEET

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

4

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.